Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mediana CoXKRX:041920 -2.54%72 EBITDA Margin % is 19.70% as of Jun. 2026, which is 7% above its 10-year median of 18.42. GuruFocus rates XKRX:041920 with a GF Score™ of 72/100 and a GF Value™ of ₩5,942.54 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Mediana Co ranks better than 64.91% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Mediana Co's EBITDA for the
three
months ended in Jun. 2026 was ₩4,165 Mil. Mediana Co's Revenue for the
three
months ended in Jun. 2026 was ₩21,144 Mil. Therefore, Mediana Co's EBITDA margin for the quarter that ended in Jun. 2026 was 19.70%.
Mediana Co (XKRX:041920) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Mediana Co EBITDA Margin % Related Terms
Mediana Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Mediana Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:041920 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Mediana Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mediana Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mediana Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Mediana Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mediana Co (XKRX:041920) has a EBITDA Margin % of 19.70% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Mediana Co and its competitors. This is near median its historical median of 18.42. Over the past decade, Mediana Co's EBITDA Margin % has ranged from 9.13 to 23.23. According to the industry distribution chart, Mediana Co ranks #286 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 35.1%.
Is Mediana Co's EBITDA Margin % too high?
Mediana Co's current EBITDA Margin % of 19.70% is near median its 10-year median of 18.42. Over the past 10 years, this metric has ranged from a low of 9.13 to a high of 23.23. The Medical Devices & Instruments industry median EBITDA Margin % is 7.90. Mediana Co's value of 19.70% is 149.4% above this industry median. Based on the distribution chart, Mediana Co ranks #286 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Mediana Co has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mediana Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Mediana Co ranks #286 out of 815 companies for EBITDA Margin %. This puts Mediana Co in the upper half of its industry. The industry median EBITDA Margin % is 7.90. Mediana Co's value of 19.70% is 149.4% above this benchmark. Historically, Mediana Co's own EBITDA Margin % has ranged from 9.13 to 23.23 over the past decade. While the company's 10-year median is 18.42 vs. the industry median of 7.90, Mediana Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.90, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mediana Co's current EBITDA Margin % of 19.70% is 149.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Mediana Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mediana Co's current EBITDA Margin % is 19.70%, which is near median its own 10-year median of 18.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mediana Co stock overvalued right now?
Based on GuruFocus' analysis, Mediana Co (XKRX:041920) is currently considered Significantly Overvalued. The stock's GF Value™ is ₩5,942.54, compared to a current price of ₩8,450.00 — trading 42.2% above its estimated fair value. The current EBITDA Margin % is 19.70%, which is near median its 10-year median of 18.42 and 149.4% above the Medical Devices & Instruments industry median of 7.90. Mediana Co's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Mediana Co (XKRX:041920), the current EBITDA Margin % is 19.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mediana Co (XKRX:041920) Overvalued in 2026?
Based on GuruFocus' analysis, Mediana Co stock appears to be overvalued.
The current stock price of ₩8,450.00 is trading 42.2% above its estimated GF Value™ of ₩5,942.54.
GuruFocus considers Mediana Co to be Significantly Overvalued.
Key valuation signals for XKRX:041920:
EBITDA Margin %: 19.70% (near median its 10-year median of 18.42)
GF Value™: ₩5,942.54 vs. price of ₩8,450.00 (42.2% above fair value)
Industry Position: 149.4% above the Medical Devices & Instruments median (#286 of 815)
No single metric tells the full story. See the XKRX:041920 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mediana Co Ltd manufactures medical equipment and devices. The company manufactures and supplies patient monitoring devices, defibrillators, and other products to domestic and international markets.
72GF Score
Get the complete analysis for XKRX:041920
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:041920 has been successfully added to your 
